Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.710
-0.180 (-9.52%)
At close: Jul 18, 2025, 4:00 PM
1.700
-0.010 (-0.58%)
After-hours: Jul 18, 2025, 6:41 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $11.60 million as of July 18, 2025. Its market cap has decreased by -10.05% in one year.
Market Cap
11.60M
Enterprise Value
6.64M
1-Year Change
-10.05%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $11.60M, a decrease of -58.70%. That is a compound annual growth rate of -10.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 10.80M | 11.34% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.71B |
| Johnson & Johnson | 393.44B |
| AbbVie | 336.66B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 262.80B |
| Novartis AG | 233.75B |
| AstraZeneca | 217.77B |
| Abbott Laboratories | 211.01B |